Dynus Medicaments Limited - Company Profile

It is a chemicals public limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Dynus Medicaments Limited

Dynus Medicaments Limited, a struck off public limited company, was established on 07 August 2012 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233TG2012PLC082344. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Hema Gadde (Director), Dinesh Kumar Gadde (Director), Aradhyula Ramakrishna (Director). It is based at 23-647/A/258, Prem Nagar, Amberpet, Hyderabad, Telangana, 500013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2012PLC082344

  • Registration Number

    082344

  • Incorporation Date

    07 August 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 9 Months
Company report

Dynus Medicaments Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Dynus Medicaments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dynus Medicaments Limited?
Current Directors
Name Designation Appointment Date Status
Hema Gadde Director 07 Aug 2012 Current
Dinesh Kumar Gadde Director 07 Aug 2012 Current
Aradhyula Ramakrishna Director 07 Aug 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dynus Medicaments.

Enhance accessibility to Dynus Medicaments's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dynus Medicaments revenue growth over time
Dynus Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dynus Medicaments?

Unlock access to Dynus Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dynus Medicaments?

Unlock and access historical data on people associated with Dynus Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dynus Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dynus Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dynus Medicaments
Recent Activity within the Organization
  • Director Appointment

    Progress on Hema Gadde was appointed as a Director was appointed as a Director on 07 Aug 2012 & has been associated with this company since 13 years 9 months . was documented.

  • Director Appointment

    Dinesh Kumar Gadde was appointed as a Director was appointed as a Director on 07 Aug 2012 & has been associated with this company since 13 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Aradhyula Ramakrishna was appointed as a Director was appointed as a Director on 07 Aug 2012 & has been associated with this company since 13 years 9 months . was documented.

  • Company Incorporation

    Progress on Dynus Medicaments Limited was registered on 07 Aug 2012 with Roc Hyderabad & aged 13 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dynus Medicaments Limited?

The CIN of Dynus Medicaments Limited is U24233TG2012PLC082344.

Where is Dynus Medicaments Limited headquartered?

Dynus Medicaments Limited is headquartered at 23-647/A/258, Prem Nagar, Amberpet, Hyderabad, Telangana, 500013.

When was Dynus Medicaments Limited incorporated?

Dynus Medicaments Limited was incorporated on 07 August 2012.

Who are the current directors of Dynus Medicaments Limited?

The current directors of Dynus Medicaments Limited are

What is the primary industry of Dynus Medicaments Limited?

The primary industry of Dynus Medicaments Limited is Chemicals.

Is Dynus Medicaments Limited a listed company?

Dynus Medicaments Limited is unlisted.

What is the capital structure of Dynus Medicaments Limited?

The authorized capital of Dynus Medicaments Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available